Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 8CBF | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs | |
| 8CMA | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-35 Fab | |
| 8CMA | 8CMA | SARS-CoV-2 Delta-RBD complexed with BA.4/5-35 Fab | |
| 8CBE | 8CBE | SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs | |
| 8CBE | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs | |
| 8CBD | 8CBD | SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs | |
| 8CBD | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs | |
| 8BBO | Q6GMX6 | SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab | |
| 8BBO | P0DOX7 | SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab | |
| 8BBO | A0A8B6RM54 | SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab | |
| 8C3V | 8C3V | SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody | |
| 8C3V | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody | |
| 8HHY | P0DTC2 | SARS-CoV-2 Delta Spike in complex with IS-9A | |
| 8HHY | 8HHY | SARS-CoV-2 Delta Spike in complex with IS-9A | |
| 8HHX | P0DTC2 | SARS-CoV-2 Delta Spike in complex with FP-12A | |
| 8HHX | 8HHX | SARS-CoV-2 Delta Spike in complex with FP-12A | |
| 7KE7 | P0DTC2 | SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification) | |
| 7KDK | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) | |
| 7KE8 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
| 7KE6 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
| 7KE4 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class) | |
| 7KDI | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) | |
| 7KEB | P0DTC2 | SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
| 7KE9 | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
| 7KEA | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification) | |
| 7KEC | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification) | |
| 7KDJ | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) | |
| 7KDL | P0DTC2 | SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) | |
| 7YBM | P0DTC2 | SARS-CoV-2 C.1.2 variant spike (Close state) | |
| 7ZFC | 7ZFC | SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | |
| 7ZFC | P0DTC2 | SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | |
| 8DF5 | 8DF5 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 8DF5 | Q9BYF1 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 8DF5 | P0DTC2 | SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
| 8FXC | Q9BYF1 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | P0DTC2 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | 8FXC | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S6M | 8S6M | SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments | |
| 8S6M | P0DTC2 | SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments | |
| 8S9G | Q9BYF1 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | P0DTC2 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | 8S9G | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | 8H07 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | 8H07 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8X5Q | P0DTC2 | SARS-CoV-2 BA.2.75 Spike with K356T mutation (3 RBD down) | |
| 8X5R | P0DTC2 | SARS-CoV-2 BA.2.75 Spike with K356T mutation (1 RBD up) | |
| 7YR1 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
| 7YR1 | 7YR1 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 |
